BILOBALIDE (1653)

Name	BILOBALIDE
Compound class	41916E7E848
Compound code	SESQUITERPENE

171 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)
357122	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
1273742	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROPROTECTANT EFFECT	Empty organism
674965	PHARMACOLOGY OF COMPOUND - IN VIVO	GABA LEVEL INCREASE	Empty organism
783533	PHARMACOLOGY OF COMPOUND - IN VITRO	VASODILATOR ACTIVITY	Empty organism
369841	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROXIDE RADICAL GENERATION INHIBITION	Empty organism
369687	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIPARASITIC ACTIVITY	Empty organism
870950	ISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
760378	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Empty organism
775730	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
704591	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Empty organism
734728	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
642520	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC		Ginkgo biloba (GINKGOACEAE)
782803	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
798037	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUTAMATE RELEASE INHIBITION	Empty organism
803980	PHARMACOLOGY OF COMPOUND - IN VITRO	NADH DEHYDROGENASE STIMULATION	Empty organism
760380	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Empty organism
647090	PHARMACOLOGY OF COMPOUND - IN VIVO	MITOCHONDRIAL RESPIRATION STIMULATION	Empty organism
547821	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Empty organism
397338	PHARMACOLOGY OF COMPOUND - IN VIVOREVIEW OF	ANTICONVULSANT ACTIVITY	Empty organism
686690	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
470153	PHARMACOLOGY OF COMPOUND - IN VIVO	NERVE REGENERATION	Empty organism
681965	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
634643	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
870951	PHARMACOLOGY OF COMPOUND - IN VITRO	FEEDING DETERRENT(INSECT)	Ginkgo biloba (GINKGOACEAE)
647112	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMIC ACID DECARBOXYLASE STIMULATION	Empty organism
479759	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANXIOLYTIC EFFECT	Empty organism
686284	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROTROPHIC ACTIVITY	Empty organism
760379	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Empty organism
766009	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
393945	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
734698	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
733433	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
704590	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN EXPRESSION INHIBITION	Empty organism
391508	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
500232	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
391498	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
416765	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
675926	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INHIBITION	Empty organism
397335	PHARMACOLOGY OF COMPOUND - IN VITROREVIEW OF	ANTIAGING ACTIVITY	Empty organism
391513	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
623557	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INHIBITION	Empty organism
750316	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY GC/MS		Ginkgo biloba (GINKGOACEAE)
617737	PRESENT IN (REVIEW)		Ginkgo biloba (GINKGOACEAE)
6936	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Ginkgo biloba (GINKGOACEAE)
671413	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICYTOTOXIC ACTIVITY	Empty organism
404434	VOUCHER SPECIMEN REPORTED FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS		Ginkgo biloba (GINKGOACEAE)
721508	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FORREVIEW OF		Ginkgo biloba (GINKGOACEAE)
349385	PHARMACOLOGY OF COMPOUND - IN VIVO	INSULIN LEVEL INCREASE	Empty organism
393538	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
459911	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROTOZOAN ACTIVITY	Empty organism
692052	ISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
395635	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
357123	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Empty organism
940960	UV SPECTRUM GIVEN FORIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
356080	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FORBIOLOGICAL TRANSFORMATION OF		Ginkgo biloba (GINKGOACEAE)
47853	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ginkgo biloba (GINKGOACEAE)
369301	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Empty organism
357120	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
743325	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
674964	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMIC ACID RELEASE STIMULATION	Empty organism
383691	WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
67497	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	MISCELLANEOUS EFFECTS	Ginkgo biloba (GINKGOACEAE)
446029	ISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
1287561	PHARMACOLOGY OF COMPOUND - IN VITRO	ELECTROPHYSIOLOGICAL EFFECTS	Ginkgo biloba (GINKGOACEAE)
445501	PHARMACOLOGY OF COMPOUND - IN VIVO	SLEEPING TIME DECREASED	Ginkgo biloba (GINKGOACEAE)
502221	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Ginkgo biloba (GINKGOACEAE)
395636	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTICONVULSANT ACTIVITY	Ginkgo biloba (GINKGOACEAE)
654656	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
416764	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
492173	PHARMACOLOGY OF COMPOUND - IN VIVO	INSULIN RELEASE STIMULATION	Empty organism
459912	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIPROTOZOAN ACTIVITY	Empty organism
445502	PHARMACOLOGY OF COMPOUND - IN VIVO	SLEEPING TIME DECREASED	Ginkgo biloba (GINKGOACEAE)
807170	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
763029	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Empty organism
729484	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
704588	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHASE INHIBITION	Empty organism
783052	SYNTHESIS OF ANALOGSISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
1285363	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRONOTROPIC EFFECT NEGATIVE	Empty organism
956150	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
547822	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Empty organism
369840	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Empty organism
944934	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
394874	PHARMACOLOGY OF COMPOUND - IN VIVO	MISCELLANEOUS EFFECTS	Empty organism
957252	IDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
397336	PHARMACOLOGY OF COMPOUND - IN VIVOREVIEW OF	NEUROPROTECTANT EFFECT	Empty organism
349382	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCOGEN CONTENT INCREASED	Empty organism
1273741	PHARMACOLOGY OF COMPOUND - IN VIVO	NEUROPROTECTANT EFFECT	Empty organism
676077	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Empty organism
397128	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Empty organism
6935	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Ginkgo biloba (GINKGOACEAE)
724078	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
547823	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Empty organism
1273840	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROPROTECTANT EFFECT	Empty organism
674963	PHARMACOLOGY OF COMPOUND - IN VIVO	GABA LEVEL INCREASE	Empty organism
623558	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INHIBITION	Empty organism
369685	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Empty organism
667759	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIOXIDANT ACTIVITY	Empty organism
788787	PHARMACOLOGY OF COMPOUND - IN VIVO	AMINO ACID LEVEL INCREASE	Empty organism
695491	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
393344	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
835991	WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESHPLC DATA REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDTLC DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
704592	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN EXPRESSION INHIBITION	Empty organism
391503	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
743326	IDENTIFICATION IN BY GLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGY		Ginkgo biloba (GINKGOACEAE)
767953	IDENTIFICATION IN BY HPLC		Ginkgo biloba (GINKGOACEAE)
647111	PHARMACOLOGY OF COMPOUND - IN VIVO	GABA LEVEL INCREASE	Empty organism
634241	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
623901	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
547819	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Empty organism
280910	ISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
355878	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
356081	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FORBIOLOGICAL TRANSFORMATION OF		Ginkgo biloba (GINKGOACEAE)
404393	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Ginkgo biloba (GINKGOACEAE)
538258	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
676078	PHARMACOLOGY OF COMPOUND - IN VIVO	MISCELLANEOUS EFFECTS	Empty organism
739284	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
280227	PHARMACOLOGY OF COMPOUND - IN VITRO	REACTIVE OXYGEN SPECIES GENERATION INHIBITION	Ginkgo biloba (GINKGOACEAE)
686075	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Empty organism
763028	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Empty organism
700431	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUTATHIONE PEROXIDASE STIMULATION	Empty organism
397333	PHARMACOLOGY OF COMPOUND - IN VITROREVIEW OF	ANTIOXIDANT ACTIVITY	Empty organism
399301	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
867421	X-RAY CHRYSTALLOGRAPHIC STUDIESIDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
763395	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
788979	PHARMACOLOGY OF COMPOUND - IN VITRO	AMINO ACID ANTAGONIST EFFECT	Empty organism
479463	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIPROTOZOAN ACTIVITY	Empty organism
678646	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Empty organism
454659	IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYTLC DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
676076	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Empty organism
349384	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Empty organism
800822	PHARMACOLOGY OF COMPOUND - IN VITRO	GABA RELEASE INHIBITION	Empty organism
524701	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL MEMBRANE STABILIZER	Empty organism
596504	PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
674967	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMIC ACID DECARBOXYLASE STIMULATION	Empty organism
524702	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Empty organism
735059	PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
416766	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
524700	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Empty organism
526213	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Ginkgo biloba (GINKGOACEAE)
674966	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMIC ACID DECARBOXYLASE STIMULATION	Empty organism
552864	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP LEVELS INCREASED	Empty organism
798327	PHARMACOLOGY OF COMPOUND - IN VITRO	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	Empty organism
354444	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
6934	PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)	CARCINOGENIC ACTIVITY	Ginkgo biloba (GINKGOACEAE)
659859	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
788768	PHARMACOLOGY OF COMPOUND - IN VIVO	NEUROPROTECTANT EFFECT	Empty organism
395638	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Ginkgo biloba (GINKGOACEAE)
397334	PHARMACOLOGY OF COMPOUND - IN VITROREVIEW OF	CARDIOTONIC ACTIVITY	Empty organism
760381	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Empty organism
704587	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Empty organism
802829	PHARMACOLOGY OF COMPOUND - IN VITRO	ANXIOLYTIC EFFECT	Empty organism
788767	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROPROTECTANT EFFECT	Empty organism
357121	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
393345	PHARMACOLOGY OF COMPOUND - IN VIVO	DEMETHYLASE INHIBITION	Empty organism
763429	IDENTIFICATION IN BY HPLCQUANTITATIVE DATAPATENT DESCRIBED		Ginkgo biloba (GINKGOACEAE)
280228	ISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
404394	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Ginkgo biloba (GINKGOACEAE)
686285	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL GROWTH ENHANCEMENT EFFECT	Empty organism
445499	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
391493	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ginkgo biloba (GINKGOACEAE)
426356	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Ginkgo biloba (GINKGOACEAE)
700430	PHARMACOLOGY OF COMPOUND - IN VITRO	HEMEOXYGENASE INDUCTION	Empty organism
647091	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOCHONDRIAL RESPIRATION STIMULATION	Empty organism
681278	PHARMACOLOGY OF COMPOUND - IN VIVO	MICROCEREBRAL CIRCULATORY ACTIVITY	Empty organism
800356	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Ginkgo biloba (GINKGOACEAE)
397337	PHARMACOLOGY OF COMPOUND - IN VIVOREVIEW OF	NEUROPROTECTANT EFFECT	Empty organism
704589	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN EXPRESSION INHIBITION	Empty organism
349383	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCOGEN CONTENT INCREASED	Empty organism
369302	PHARMACOLOGY OF COMPOUND - IN VIVO	MISCELLANEOUS EFFECTS	Empty organism
547820	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Empty organism
369686	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIFUNGAL ACTIVITY	Empty organism

BILOBALIDE (1653)

Compound Details

Summary

Experiments (171)

Filters

Worktypes (33)

Pharmacology (58)

Compounds (44)

Organisms (119)

Show SPARQL Queries (1)

Query 1